Resistance Exercise in Hemodialysis Patients

NCT ID: NCT06604221

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-03

Study Completion Date

2025-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if an intradialytic resistance exercise intervention works to reduce the symptom burden in older maintenance hemodialysis patients. It will also learn about safety of the intradialytic resistance exercise intervention program. The main questions it aims to answer are:

1. Does intradialytic resistance exercise effectively improve the number, frequency, and severity of symptoms in older patients?
2. What adverse events may occur among older dialysis patients during exercise?

Researchers will compare older dialysis patients who undergo the intradialytic resistance exercise intervention with those receiving standard care to observe whether resistance exercise can improve symptom burden.

Participants will:

1. Take an intradialytic resistance exercise intervention program developed through joint decision-making by rehabilitation experts, dialysis center physicians, nurses, and patients, conducted three times a week for 20 minutes each session, over a duration of three months.
2. Visit the hospital a monthly for texts and examinations.
3. Keep a diary of the types and frequency of adverse events during and after the exercise sessions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Resistance Exercise Intervention Group

Resistance exercise intervention plan, developed through expert meetings and integrated review summaries, consists of 27 items including: participant preparation, team preparation, exercise prescription FITT-VP, process monitoring, discontinuation criteria, termination criteria, recovery methods, outcome measures, and special considerations.

Group Type EXPERIMENTAL

Resistance exercise intervention

Intervention Type BEHAVIORAL

The exercise prescription, developed through expert meetings and integrated review summaries, consists of 27 items including: participant preparation, team preparation, exercise prescription FITT-VP, process monitoring, discontinuation criteria, termination criteria, recovery methods, outcome measures, and special considerations.

Routine care

Intervention Type BEHAVIORAL

1.Pre-dialysis Assessment:

1. Vital Signs: Monitor blood pressure, heart rate, temperature.
2. Access Care: Check the vascular access site for signs of infection and patency. 2.During Dialysis:

(1)Monitoring: Continuous vital signs and machine settings monitoring. (2)Fluid Management: Control fluid removal based on pre-dialysis weight. 3.Post-dialysis Care:

1. Observation: Monitor for complications like hypotension, cramps, or bleeding.
2. Weight Check: Weigh post-dialysis to verify fluid removal. 4.Education and Support:

(1)Diet: Educate on dietary restrictions (potassium, phosphorus, fluids). (2)Medications: Advise on medication adjustments. 5.Psychosocial Support:

(1)Provide emotional support and counseling.

control group

Routine care

Group Type ACTIVE_COMPARATOR

Routine care

Intervention Type BEHAVIORAL

1.Pre-dialysis Assessment:

1. Vital Signs: Monitor blood pressure, heart rate, temperature.
2. Access Care: Check the vascular access site for signs of infection and patency. 2.During Dialysis:

(1)Monitoring: Continuous vital signs and machine settings monitoring. (2)Fluid Management: Control fluid removal based on pre-dialysis weight. 3.Post-dialysis Care:

1. Observation: Monitor for complications like hypotension, cramps, or bleeding.
2. Weight Check: Weigh post-dialysis to verify fluid removal. 4.Education and Support:

(1)Diet: Educate on dietary restrictions (potassium, phosphorus, fluids). (2)Medications: Advise on medication adjustments. 5.Psychosocial Support:

(1)Provide emotional support and counseling.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resistance exercise intervention

The exercise prescription, developed through expert meetings and integrated review summaries, consists of 27 items including: participant preparation, team preparation, exercise prescription FITT-VP, process monitoring, discontinuation criteria, termination criteria, recovery methods, outcome measures, and special considerations.

Intervention Type BEHAVIORAL

Routine care

1.Pre-dialysis Assessment:

1. Vital Signs: Monitor blood pressure, heart rate, temperature.
2. Access Care: Check the vascular access site for signs of infection and patency. 2.During Dialysis:

(1)Monitoring: Continuous vital signs and machine settings monitoring. (2)Fluid Management: Control fluid removal based on pre-dialysis weight. 3.Post-dialysis Care:

1. Observation: Monitor for complications like hypotension, cramps, or bleeding.
2. Weight Check: Weigh post-dialysis to verify fluid removal. 4.Education and Support:

(1)Diet: Educate on dietary restrictions (potassium, phosphorus, fluids). (2)Medications: Advise on medication adjustments. 5.Psychosocial Support:

(1)Provide emotional support and counseling.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

intra dialysis resistance exercise Routine care for hemodialysis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age 60 years and above Stable on dialysis for ≥3 months Able to walk independently, no physical disability, and muscle strength ≥ Grade III Capable of understanding and complying with the requirements of this study Voluntarily signed an informed consent form

Exclusion Criteria

Severe cardiovascular, cerebrovascular, respiratory, or neurological diseases, or other conditions that impair physical ability to exercise Serious infections, bleeding, trauma, or other conditions affecting physical status within the last 3 months Severe mental disorders or cognitive impairments Abnormal blood pressure (pre-dialysis systolic pressure ≥180mmHg, diastolic pressure ≥100mmHg) Hemoglobin (Hb) \< 90g/L, Albumin (Alb) ≤ 32g/L Participation in other exercise or pharmacological interventions in the past 6 months
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shengjing Hospital

OTHER

Sponsor Role collaborator

Teng Zeng

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Teng Zeng

Graduate student

Responsibility Role SPONSOR_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zeng Teng, Graduate Student

Role: CONTACT

+86 13096390520

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024148

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.